Table: Astellas -2025/26 parent results

Astellas Pharma

27/04/2026 07:30

Apr 27 (Reuters)- 
          Astellas Pharma Inc. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Mar 31, 2026    Mar 31, 2025   Mar 31, 2027     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            888.13          789.62                                
                 (+12.5 pct)     (+14.7 pct)                             
  Operating        273.40          267.31                                
                 (+2.3 pct)      (+37.8 pct)                             
  Recurring        513.06          431.12                                
                 (+19.0 pct)     (+15.5 pct)                             
  Net              368.02          319.72                                
                 (+15.1 pct)     (+9.4 pct)                              
  EPS            205.47 yen      178.59 yen                              
  EPS Diluted    205.43 yen      178.55 yen                              
  Ann Div         78.00 yen       74.00 yen      80.00 yen               
  -Q2 Div         39.00 yen       37.00 yen      40.00 yen               
  -Q4 Div         39.00 yen       37.00 yen      40.00 yen               
  
  NOTE - Astellas Pharma Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4503.T